Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Subscribe To Our Newsletter & Stay Updated